遗传视网膜变形症的基因疗法的进步和挑战:综合性审查
Raina Jain1, Sachin Daigavane1
1Ophthalmology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education & Research, Wardha, IND.
Cureus
|October 23, 2024
概括
基因疗法为遗传视网膜变症 (IRDs) 提供了新的希望,这是一组导致视力丧失的遗传性疾病. 研究正在推进治疗方法,以恢复视力和阻止IRD的疾病进展.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 遗传性视网膜发育不良 (IRDs) 是一种遗传性疾病,导致渐进的视力丧失.
- 视网膜光受体退化是IRD的主要病理.
- 基因疗法为IRDs提供了一个潜在的治疗策略.
研究的目的:
- 为IRDs提供基因疗法创新的全面审查.
- 讨论IRD的基因治疗机制,最近的进展和挑战.
- 探索未来的方向并提高视网膜疾病的治疗疗效.
主要方法:
- 对IRDs的基因治疗现有文献的综述.
- 讨论病毒和非病毒载体系统.
- 检查基因编辑技术,如CRISPR/Cas9.
主要成果:
- 对于RPE65介导的视网膜变的Luxturna批准标志着一个重要的里程碑.
- 基因疗法载体和输送方法的进展正在进行中.
- 挑战包括载体传递,长期安全性和患者反应的变化.
结论:
- 基因疗法对治疗IRD和恢复视力具有重大前景.
- 进一步的研究对于克服现有挑战和改善治疗结果至关重要.
- 基因疗法的创新可以改变视网膜疾病的管理.
相关概念视频
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1


